PDF
Conviction scores reflect our analytical assessment and are not recommendations to buy, sell, or hold any security. These ratings do not take into account any individual subscriber’s financial situation, investment objectives, or risk tolerance.
Mercury Systems is a structurally advantaged, hard-to-replicate supplier of secure, trusted mission-processing electronics into a multi-year defense modernization supercycle, a real infrastructure position with a $1.6B record backlog and ITAR and trusted-foundry barriers competitors cannot cheaply cross. The Ballhaus turnaround is genuine and the macro tailwind is durable. But the stock has roughly doubled in a year, trades above consensus on margins still about half of management's own goal, and is pricing a fully recovered Mercury that does not yet exist.
Visionary and Macro Man define a strong thesis spine. Mercury sits at the intersection of US defense modernization, NATO rearmament to 3%+ GDP, electronic-warfare, radar and missile-defense demand, and the mandated domestic trusted-microelectronics ecosystem, a structural regulatory moat. Operator confirms the moat is real: 10 to 30 year program design-in lock-in, cleared and TS/SCI manufacturing, $1.6B record backlog, 1.48x book-to-bill. The turnaround shows in the numbers, adj. EBITDA margin 15.3% versus 11.7% a year ago, free cash flow positive after years of pain. Electronic warfare is a large, fast-growing market, and Mercury is a picks-and-shovels supplier to that spend.
Skeptic and Quant carry the warning. The recovery is incomplete and priced as if complete: a 15.3% adj. EBITDA margin is still about half the mid-20s target; TTM free cash flow has already re-decelerated to $73.5M from $119.0M; Q3 free cash flow was actually negative at roughly $1.8M. Valuation is extreme, around 78x EV/EBITDA, roughly 73x forward earnings, about 6.8x sales on a still-GAAP-loss business, above consensus, with Goldman Sachs at a Sell, $68. Thesis killer: an estimate-at-completion charge in the tens of millions on a ramping fixed-price program would crack both the margin narrative and the multiple at once.
The bull case wins on the business and loses on the entry. The moat and backlog are real, the turnaround is structurally sound, and the macro tailwind is bipartisan and multi-year. What does not hold up is the valuation math. At roughly 78x EV/EBITDA on margins still half of target, above consensus, with Goldman at a Sell ($68) and zero insider buying into a stock that has doubled, the price embeds flawless execution, which is the one thing a half-finished turnaround cannot promise. The intent is to own Mercury, just not at $109. That is why this is Accumulate / Watch, not Buy.
| Metric | Value | Note |
|---|---|---|
| Price | $109.38 | June 26, 2026 close; above ~$101.50 consensus high |
| Revenue (TTM) | ~$967M | +8.6% YoY; +11.5% organic Q3 |
| Backlog | ~$1.6B record | Book-to-bill 1.48x; $891M within 12 months |
| Adj. EBITDA margin | 15.3% (Q3) | vs 11.7% yr-ago; target mid-20s |
| Gross Margin | 28.7% TTM | 29.3% Q3; vs FY21 peak ~41.7% |
| GAAP EPS (TTM) | -$0.24 | Still loss-making |
| FCF (TTM) | $73.5M | down from $119.0M FY25; Q3 -$1.8M |
| EV/EBITDA | ~78x | as of June 26; vs A&D peers ~15–28x |
| Fwd P/E | ~73x | as of June 26; prices full recovery |
| P/S (TTM) | ~6.8x | on a still-GAAP-loss business |
| Rule of 40 | Fail | margin still well below target |
| Net Debt | ~$260M spot | ~$110M pro-forma after $150M revolver repaid Apr 30 |
| Short Interest | ~7.7% | of float; June 15 settlement |
Valuation multiples (EV/EBITDA, forward P/E, P/S, short interest) as of the June 26, 2026 close. Filing-based figures per the 10-Q (quarter ended March 27, 2026), 10-K (FY ended June 27, 2025), and Q3-FY26 press release.
Position sizes are illustrative only and are for general guidance purposes, not investment advice. Please determine appropriate position sizes based on your own financial circumstances, risk tolerance and investment objectives.
Staged, dollar-cost entry over 8 to 12 weeks rather than a lump-sum purchase here. The name overlaps existing defense and aerospace exposure, so size down if the theme is already held. Worst case is a margin relapse paired with a fresh estimate-at-completion charge, which would retest the $45 to $68 zone, a drawdown on the order of 50 to 55% (the historical max drawdown ran near 72% from the 2020 peak to the 2024 trough). The cleanest expression is a small starter only on a pullback into the $90 to $100 structural support zone, then building on thesis confirmation: margins marching toward 20%, clean free cash flow, and book-to-bill holding above 1.
This report is produced and published by Otto Analytics, LLC ("the Company") and is provided for informational and educational purposes only. It is general in nature, does not constitute investment, financial, legal, or tax advice, and does not take into account the individual circumstances, objectives, financial situation, or risk tolerance of any reader.
No advisory relationship. Nothing here creates an investment-advisory, fiduciary, or other client relationship between you and the Company. The Company is not a registered investment adviser or broker-dealer. The Company does not provide advice attuned to any specific portfolio or to any subscriber’s particular needs. All content is impersonal commentary offered uniformly to all subscribers.
Conviction scores. Conviction scores reflect our analytical assessment and are not recommendations to buy, sell, or hold any security. These ratings do not take into account any individual subscriber’s financial situation, investment objectives, or risk tolerance.
Position sizing. Position sizes are illustrative only and are for general guidance purposes, not investment advice. Please determine appropriate position sizes based on your own financial circumstances, risk tolerance and investment objectives.
Not an offer or solicitation. Nothing here is an offer to sell, or a solicitation of an offer to buy, any security.
AI-assisted content. AI tools may be used in preparing this analysis. Human editorial review is required before publication. AI assistance and human review do not eliminate the possibility of errors, omissions, or inaccuracies. Data may be drawn from third-party sources believed to be reliable but not guaranteed to be accurate or current.
Risk of loss. All investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. Forward-looking statements are inherently uncertain and should not be relied upon as predictions of actual future events.
Personal positions. The Company or its personnel may hold positions in securities discussed. Our commentary reflects disinterested analysis, and any personal holdings may be disclosed on our website.
Independent decisions. You are solely responsible for your own investment decisions and for executing your own trades. You should consult a licensed financial professional, attorney, and/or tax advisor before making any investment decision.
By accessing this report, you acknowledge and agree to the foregoing. This disclaimer is governed by the laws of the State of Oregon.